	Personal Care
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	338,325		49.3	%	$	324,670		50.2	%	$	303,479		52.2	%
Managed care organizations		311,801		45.5			287,032		44.3			239,559		41.3
Private pay		19,991		2.9			20,398		3.2			21,765		3.7
Commercial insurance		9,820		1.4			9,991		1.5			9,204		1.6
Other		5,917		0.9			5,142		0.8			6,721		1.2
Total personal care segment net service revenues	$	685,854		100.0	%	$	647,233		100.0	%	$	580,728		100.0	%

	Hospice
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	142,086		93.3	%	$	94,068		92.9	%	$	49,649		92.6	%
Managed care organizations		5,664		3.7			4,931		4.9			2,768		5.2
Other		4,503		3.0			2,298		2.2			1,184		2.2
Total hospice segment net service revenues	$	152,253		100.0	%	$	101,297		100.0	%	$	53,601		100.0	%

	Home Health
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	20,700		78.4	%	$	12,765		78.6	%	$	11,218		77.6	%
Managed care organizations		4,457		16.9			3,188		19.6			2,942		20.3
Other		1,235		4.7			292		1.8			302		2.1
Total home health segment net service revenues	$	26,392		100.0	%	$	16,245		100.0	%	$	14,462		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico and New York. The percentages of segment revenue for each of these significant states for 2021, 2020 and 2019 were as follows:

	Personal Care
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	328,619		47.9	%	$	288,326		44.6	%	$	247,524		42.6	%
New York		99,732		14.5			115,510		17.8			108,403		18.7
New Mexico		97,784		14.3			86,618		13.4			75,666		13.0
All other states		159,719		23.3			156,779		24.2			149,135		25.7
Total personal care segment net service revenues	$	685,854		100.0	%	$	647,233		100.0	%	$	580,728		100.0	%

	Hospice
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Ohio	$	61,415		40.3	%	$	—		—	%	$	—		—	%
New Mexico		36,063		23.7			42,648		42.1			38,790		72.4
All other states		54,775		36.0			58,649		57.9			14,811		27.6
Total hospice segment net service revenues	$	152,253		100.0	%	$	101,297		100.0	%	$	53,601		100.0	%

With the acquisition of Queen City Hospice, the Company expanded its hospice services in the state of Ohio.

	Home Health
	For the Years Ended December 31,
	2021					2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	24,735		93.7	%	$	16,245		100.0	%	$	14,462		100.0	%
Illinois		1,657		6.3			—		—			—		—
Total home health segment net service revenues	$	26,392		100.0	%	$	16,245		100.0	%	$	14,462		100.0	%

With the acquisition of Summit, the Company expanded its home health services in the state of Illinois.

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented 38.2%, 37.7% and 38.2% of our net service revenues for the years ended December 31, 2021, 2020 and 2019, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 21.4%, 23.0% and 25.3% of the Company’s net service revenues for 2021, 2020 and 2019, respectively.

The related receivables due from the Illinois Department on Aging represented 16.1% and 15.9% of the Company’s net accounts receivable at December 31, 2021 and 2020, respectively.

In 2019, New York initiated a new Request For Offer (“RFO”) process to competitively procure CDPAP fiscal intermediaries. The Company was not selected in the initial RFO process. We submitted a formal protest in response to the selection process, which was filed and accepted in March 2021, but have not yet received a response to the formal protest. The Company recognized approximately $42 million and $3 million in net service revenue and operating income, respectively, from the program for the year ended December 31, 2021.

The New York fiscal year 2022 state budget included a provision to add additional fiscal intermediaries (one or two entities per county with specified population sizes, plus entities that meet various other requirements) to those awarded contracts as a Lead Fiscal Intermediary under the initial RFO process, based on the scoring of the original RFO. As scoring of RFOs was not publicly released, it is unknown at this time if the Company’s score ranked high enough to qualify for these additional awards. The Company has submitted a response to the survey issued by the New York Department of Health to determine the additional contract awards. The New York Department of Health published an anticipated contract start date for all awards to be no earlier than November 1, 2021, but has not yet announced the exact start date. No later than the contract start date, we will be required to begin transitioning patients within the CDPAP to a fiscal intermediary that has been awarded a contract and cease providing services to those patients. The Company continues to consider other arrangements and to pursue our protest of the award. Given the uncertainty surrounding the program, the Company has suspended materially all of its new patient admissions under the New York CDPAP program.